Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HDAC3–HSP90AA1–PGC-1α mitochondrial regulatory axis is a specialized protein complex that coordinates mitochondrial biogenesis and metabolic adaptation in response to cellular stress. Histone Deacetylase 3 (HDAC3) serves as a key enzymatic component that deacetylates the transcriptional coactivator PGC-1α, typically leading to its inactivation and subsequent reduction in mitochondrial gene expression (UniProt O15379, Q9UBK2). This interaction is stabilized and regulated by the molecular chaperone Heat Shock Protein 90 Alpha (HSP90AA1), which ensures the proper folding and assembly of the regulatory complex (UniProt P07900). In pathological conditions such as diabetic cardiomyopathy and nonalcoholic fatty liver disease, this axis is often overactive or dysregulated, resulting in profound mitochondrial dysfunction and impaired energy metabolism (PubMed: 31235512). Pharmacological intervention using selective HDAC3 inhibitors, such as RGFP966, has been shown to disrupt this negative regulation, thereby increasing PGC-1α activity and restoring mitochondrial health (PubMed: 28467923). Consequently, this axis represents a promising therapeutic target for treating metabolic and degenerative diseases characterized by mitochondrial failure.
Inhibition of HDAC3 within the axis prevents the deacetylation of PGC-1α, thereby increasing its transcriptional activity and promoting the expression of nuclear-encoded mitochondrial genes. HSP90 modulators may further influence the stability of this regulatory complex.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone deacetylase 3–Heat shock protein 90 alpha–Peroxisome proliferator-activated receptor gamma coactivator 1-alpha mitochondrial regulatory axis (HDAC3–HSP90AA1–PGC-1α axis).